PhRMA Warns of Dire Consequences if Medicare Allowed to Negotiate Drug Prices
WASHINGTON — Pharmaceutical industry representatives said Wednesday that proposals now being considered on Capitol Hill to lower patients’ prescription drug costs likely will have damaging effects on new drug development and on patients’ access to new medications. As part of a $3.5 trillion infrastructure bill, “lawmakers want to offset this amount of new spending by […]